Commodore Capital LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.29B2026 Q3
Positions37
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.65.2%

Commodore Capital LP reported 37 positions worth $1.29B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RLAY (16.8%). Biggest move: reduce AMLX ($106.2M).

10 / 37 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 RLAYRelay Therapeutics$216.6M16.78%12,000,000——-4.3%
▸ 2 ELVNEnliven Therapeutics$150.1M11.63%3,275,000——+3.9%
▸ 3 ALKSAlkermes$116.5M9.03%2,875,360——+14.8%
▸ 4 ANROAlto Neuroscience$69.5M5.39%2,723,196——+6.2%
▸ 5 SYRESpyre Therapeutics$62.3M4.83%700,000——+16.8%
▸ 6 AMLXAmylyx Pharmaceuticals$58.2M4.51%2,000,000——-4.5%
▸ 7 LBRXLB Pharmaceuticals$49.2M3.81%1,282,273———
▸ 8 DMRADamora Therapeutics$41.3M3.20%1,939,000——+1.5%
▸ 9 COGTCogent Biosciences$40.5M3.14%1,265,000——-10.8%
▸ 10 TYRATyra Biosciences$37.7M2.92%1,725,000——-8.5%

Pro Feature

The remaining 27 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Commodore Capital LP hold as of Q3 2026?

Commodore Capital LP reported 37 positions worth $1.29B in its Q3 2026 13F filing. Largest positions: RLAY (16.8%), ELVN (11.6%), ALKS (9.0%), ANRO (5.4%) and SYRE (4.8%).

What did Commodore Capital LP buy in Q3 2026?

New positions: DMRA, SRZN, KRSA, SGMT and ADRX (11 in all). Added to: IFRX and RLMD.

What did Commodore Capital LP sell in Q3 2026?

Reduced: AMLX, COGT, DFTX, ASMB and PHVS (11 in all). Sold out entirely: TNGX, EYPT, DAMORA THERAPEUTICS INC, CATX and NUVLEUR (7 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.